These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

191 related items for PubMed ID: 9864174

  • 1. Comparison of interleukin-1 beta expression by in situ hybridization in monoclonal gammopathy of undetermined significance and multiple myeloma.
    Lacy MQ, Donovan KA, Heimbach JK, Ahmann GJ, Lust JA.
    Blood; 1999 Jan 01; 93(1):300-5. PubMed ID: 9864174
    [Abstract] [Full Text] [Related]

  • 2. Contrast in cytokine expression between patients with monoclonal gammopathy of undetermined significance or multiple myeloma.
    Donovan KA, Lacy MQ, Kline MP, Ahmann GJ, Heimbach JK, Kyle RA, Lust JA.
    Leukemia; 1998 Apr 01; 12(4):593-600. PubMed ID: 9557619
    [Abstract] [Full Text] [Related]

  • 3. IL-1beta expression in IgM monoclonal gammopathy and its relationship to multiple myeloma.
    Donovan KA, Lacy MQ, Gertz MA, Lust JA.
    Leukemia; 2002 Mar 01; 16(3):382-5. PubMed ID: 11896542
    [Abstract] [Full Text] [Related]

  • 4. Clonal circulating cells are common in plasma cell proliferative disorders: a comparison of monoclonal gammopathy of undetermined significance, smoldering multiple myeloma, and active myeloma.
    Billadeau D, Van Ness B, Kimlinger T, Kyle RA, Therneau TM, Greipp PR, Witzig TE.
    Blood; 1996 Jul 01; 88(1):289-96. PubMed ID: 8704185
    [Abstract] [Full Text] [Related]

  • 5. Expression of interleukin-1beta and tumour necrosis factor-alpha in plasma cells from patients with multiple myeloma.
    Sati HI, Greaves M, Apperley JF, Russell RG, Croucher PI.
    Br J Haematol; 1999 Feb 01; 104(2):350-7. PubMed ID: 10050719
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Monoclonal gammopathy of undetermined significance and smoldering multiple myeloma.
    Kyle RA, San-Miguel JF, Mateos MV, Rajkumar SV.
    Hematol Oncol Clin North Am; 2014 Oct 01; 28(5):775-90. PubMed ID: 25212882
    [Abstract] [Full Text] [Related]

  • 11. Cytokine and chemokine profiles in multiple myeloma; significance of stromal interaction and correlation of IL-8 production with disease progression.
    Kline M, Donovan K, Wellik L, Lust C, Jin W, Moon-Tasson L, Xiong Y, Witzig TE, Kumar S, Rajkumar SV, Lust JA.
    Leuk Res; 2007 May 01; 31(5):591-8. PubMed ID: 16879867
    [Abstract] [Full Text] [Related]

  • 12. The progression from MGUS to smoldering myeloma and eventually to multiple myeloma involves a clonal expansion of genetically abnormal plasma cells.
    López-Corral L, Gutiérrez NC, Vidriales MB, Mateos MV, Rasillo A, García-Sanz R, Paiva B, San Miguel JF.
    Clin Cancer Res; 2011 Apr 01; 17(7):1692-700. PubMed ID: 21325290
    [Abstract] [Full Text] [Related]

  • 13. CD117 expression in gammopathies is associated with an altered maturation of the myeloid and lymphoid hematopoietic cell compartments and favorable disease features.
    Schmidt-Hieber M, Pérez-Andrés M, Paiva B, Flores-Montero J, Perez JJ, Gutierrez NC, Vidriales MB, Matarraz S, San Miguel JF, Orfao A.
    Haematologica; 2011 Feb 01; 96(2):328-32. PubMed ID: 20971816
    [Abstract] [Full Text] [Related]

  • 14. New insights in the clinical biology of multiple myeloma.
    Bataille R.
    Semin Hematol; 1997 Jan 01; 34(1 Suppl 1):23-8. PubMed ID: 9122743
    [Abstract] [Full Text] [Related]

  • 15. Correlation of cytomorphology, immunophenotyping, and interphase fluorescence in situ hybridization in 381 patients with monoclonal gammopathy of undetermined significance and 301 patients with plasma cell myeloma.
    Bacher U, Haferlach T, Kern W, Alpermann T, Schnittger S, Haferlach C.
    Cancer Genet Cytogenet; 2010 Dec 01; 203(2):169-75. PubMed ID: 21156229
    [Abstract] [Full Text] [Related]

  • 16. 99mTc-sestamibi imaging and bone marrow karyotyping in the assessment of multiple myeloma and MGUS.
    Giovanella L, Taborelli M, Ceriani L, Zucca E, Cavalli F, Delaloye AB.
    Nucl Med Commun; 2008 Jun 01; 29(6):535-41. PubMed ID: 18458600
    [Abstract] [Full Text] [Related]

  • 17. Identification of two groups of smoldering multiple myeloma patients who are either high or low producers of interleukin-1.
    Xiong Y, Donovan KA, Kline MP, Gornet MK, Moon-Tasson LL, Lacy MQ, Dispenzieri A, Gertz MA, Greipp PR, Lust JA.
    J Interferon Cytokine Res; 2006 Feb 01; 26(2):83-95. PubMed ID: 16487028
    [Abstract] [Full Text] [Related]

  • 18. MGUS and smoldering multiple myeloma: update on pathogenesis, natural history, and management.
    Rajkumar SV.
    Hematology Am Soc Hematol Educ Program; 2005 Feb 01; ():340-5. PubMed ID: 16304401
    [Abstract] [Full Text] [Related]

  • 19. Production of interleukin-1 by bone marrow myeloma cells.
    Cozzolino F, Torcia M, Aldinucci D, Rubartelli A, Miliani A, Shaw AR, Lansdorp PM, Di Guglielmo R.
    Blood; 1989 Jul 01; 74(1):380-7. PubMed ID: 2665838
    [Abstract] [Full Text] [Related]

  • 20. Interleukin-6 is expressed by plasma cells from patients with multiple myeloma and monoclonal gammopathy of undetermined significance.
    Sati HI, Apperley JF, Greaves M, Lawry J, Gooding R, Russell RG, Croucher PI.
    Br J Haematol; 1998 May 01; 101(2):287-95. PubMed ID: 9609524
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.